The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Buhlmann Laboratories sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Buhlmann Laboratories AG (Buhlmann) develops and manufacturers in vitro diagnostic products. The company’s products include cap collection set and quantum blue diagnostic test kit. It markets its products under the brands including Ibdoc, CalApp, Buhlmann fCAL, Calex, Cast, Quantum Blue, GanglioCombi. These products and services are used in various industries for diagnostic work and research activities, particularly in the areas of gastroenterology, autoimmunity, cellular allergy, and neuroimmunology. The company operates in Switzerland and Germany. Buhlmann is headquartered in Arlesheim, Switzerland. Key subsidiaries of Buhlmann Laboratories include Buhlmann Italia, Buhlmann in Austria, Buhlmann France, Buhlmann Diagnostics and Buhlmann Brasil.
The key metrics of Buhlmann Laboratories related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Buhlmann Laboratories is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Buhlmann Laboratories.
For a detailed understanding of the performance of Buhlmann Laboratories, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
